BioNano Genomics Stock News

SAN DIEGO, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its Symposium 2023 lineup of 30 oral presentations delivered from 27 different customers worldwide

With the Nasdaq Composite having risen a robust 6% in the first two weeks of the New Year, it appears that the exchange, in line with my previous predictions, is well on its way to entering a bull mar

SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a collaboration with NVIDIA to develop an acceleration platform for use in Bionano’s optical gen

4 Biotech Penny Stocks To Watch, January 2023 The post Best Penny Stocks To Buy? 4 To Watch In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

This could be a great day for medical science as well as for investors of Bionano Genomics (NASDAQ: BNGO ) stock. The biotech company just announced the publication of results concerning a proposed me

4 Biotech Penny Stocks To Watch, January 2023 The post Best Penny Stocks To Buy? 4 To Watch In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Here is how Bionano Genomics, Inc. (BNGO) and Exact Sciences (EXAS) have performed compared to their sector so far this year.

Here is how Bionano Genomics, Inc. (BNGO) and Exact Sciences (EXAS) have performed compared to their sector so far this year.

Upgrades For Algonquin Power & Utilities Corp (NYSE:AQN), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Algonquin Power showed an EPS of $0.11, compared

A bull-bear battle is starting to materialize in the stock market, and I believe that the struggle will intensify in early 2023. Bears believe that we're heading for a steep recession and a horrible m

Investors have high expectations for Bionano Genomics, but they might not pan out.

Investors have high expectations for Bionano Genomics, but they might not pan out.

Choosing the best drug stocks to buy can be dicey because drug stocks have disadvantages and advantages. On the negative side, you often have to wait many years for promising drugs to prove themselves

Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. Lanvin Group (NASDAQ

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Guardant Health, Inc. (NASDAQ: GH) dropped 33.1% to $27.59 in pre-mark